Intervention Protocol

3,4-Diaminopyridine for myasthenia gravis

  1. Charlotte Vrinten1,*,
  2. Stephanie S. Weinreich1,
  3. Rob JPM Scholten2,
  4. Jan JGM Verschuuren3

Editorial Group: Cochrane Neuromuscular Group

Published Online: 15 FEB 2012

DOI: 10.1002/14651858.CD009675

How to Cite

Vrinten C, Weinreich SS, Scholten RJPM, Verschuuren JJGM. 3,4-Diaminopyridine for myasthenia gravis (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD009675. DOI: 10.1002/14651858.CD009675.

Author Information

  1. 1

    VU University Medical Center, Community Genetics Section, Clinical Genetics, 1007 MB Amsterdam, Netherlands

  2. 2

    Academic Medical Center, Dutch Cochrane Centre, Amsterdam, Netherlands

  3. 3

    Leiden University Medical Center, Department of Neurology, Leiden, Netherlands

*Charlotte Vrinten, Community Genetics Section, Clinical Genetics, VU University Medical Center, BS7, D420, PO Box 7057, 1007 MB Amsterdam, Netherlands.

Publication History

  1. Publication Status: New
  2. Published Online: 15 FEB 2012


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.